Company Filing History:
Years Active: 2000-2002
Title: Shimon Efrat: Innovator in Medical Biotechnology
Introduction
Shimon Efrat is a distinguished inventor based in the Bronx, NY. He has made significant contributions to the field of medical biotechnology, particularly in the area of gene therapy and transplantation. With a total of 4 patents, Efrat's work has the potential to transform treatment methodologies for various medical conditions.
Latest Patents
Efrat's latest patents include groundbreaking inventions aimed at improving transplant success rates and diabetes treatment. One notable patent is for the "Attenuation of rejected cells transformed with adenovirus E3." This invention provides a method and vectors to express genes derived from a virus that block allograft rejection. By preventing the appearance of MHC class I products on the surface of transplanted cells, the host's immune system is less likely to reject the graft. Additionally, this invention targets pancreatic β-cells, offering a potential treatment for diabetes mellitus. Another significant patent is for "Recombinant cells regulated by tetracycline," which describes a recombinant cell whose proliferation is controlled by tetracycline or its derivatives.
Career Highlights
Efrat is affiliated with the Albert Einstein College of Medicine, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in clinical settings, particularly in enhancing the efficacy of organ transplants and diabetes management.
Collaborations
Throughout his career, Efrat has collaborated with notable colleagues, including Michael A. Brownlee and Marshall S. Horwitz. These partnerships have further enriched his research and contributed to the development of innovative solutions in medical biotechnology.
Conclusion
Shimon Efrat's contributions to the field of medical biotechnology are noteworthy, with his patents paving the way for advancements in transplant medicine and diabetes treatment. His ongoing work at the Albert Einstein College of Medicine continues to inspire innovation in healthcare.